ACELYRIN, INC Correlations
SLRN Stock | USD 2.75 0.06 2.23% |
The current 90-days correlation between ACELYRIN, INC Common and Park Electrochemical is 0.06 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ACELYRIN, INC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ACELYRIN, INC Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
ACELYRIN, INC Correlation With Market
Significant diversification
The correlation between ACELYRIN, INC Common and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ACELYRIN, INC Common and DJI in the same portfolio, assuming nothing else is changed.
ACELYRIN, |
Moving together with ACELYRIN, Stock
0.66 | ZURA | Zura Bio Limited | PairCorr |
0.64 | MLTX | MoonLake Immunotherapeuti | PairCorr |
0.7 | MLYS | Mineralys Therapeutics, Trending | PairCorr |
0.89 | PEPG | PepGen | PairCorr |
0.64 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.76 | AMLX | Amylyx Pharmaceuticals | PairCorr |
0.69 | TERN | Terns Pharmaceuticals Downward Rally | PairCorr |
Moving against ACELYRIN, Stock
0.75 | ETON | Eton Pharmaceuticals | PairCorr |
0.72 | NBY | NovaBay Pharmaceuticals | PairCorr |
0.58 | ZVSA | ZyVersa Therapeutics | PairCorr |
0.4 | VIGL | Vigil Neuroscience | PairCorr |
0.39 | PFE | Pfizer Inc | PairCorr |
0.64 | BDX | Becton Dickinson | PairCorr |
0.6 | MDT | Medtronic PLC | PairCorr |
0.56 | SMMT | Summit Therapeutics PLC | PairCorr |
0.5 | COLL | Collegium Pharmaceutical | PairCorr |
0.5 | ELMD | Electromed | PairCorr |
Related Correlations Analysis
-0.26 | 0.13 | -0.36 | 0.0 | 0.53 | 0.41 | FQVTF | ||
-0.26 | 0.48 | 0.81 | 0.0 | -0.67 | -0.59 | PKE | ||
0.13 | 0.48 | 0.24 | 0.0 | -0.38 | 0.05 | COCO | ||
-0.36 | 0.81 | 0.24 | 0.0 | -0.71 | -0.85 | SHIM | ||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | LBEV | ||
0.53 | -0.67 | -0.38 | -0.71 | 0.0 | 0.67 | BUD | ||
0.41 | -0.59 | 0.05 | -0.85 | 0.0 | 0.67 | CTYMF | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between ACELYRIN, Stock performing well and ACELYRIN, INC Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ACELYRIN, INC's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
FQVTF | 2.06 | 0.13 | 0.11 | (1.13) | 2.03 | 4.40 | 28.04 | |||
PKE | 1.31 | (0.04) | 0.00 | (0.19) | 0.00 | 2.20 | 7.97 | |||
COCO | 1.58 | 0.06 | 0.00 | (0.06) | 0.00 | 4.21 | 19.52 | |||
SHIM | 3.70 | (0.77) | 0.00 | 21.22 | 0.00 | 7.96 | 25.88 | |||
LBEV | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
BUD | 1.06 | 0.28 | 0.22 | 0.51 | 1.32 | 2.29 | 8.16 | |||
CTYMF | 3.33 | 0.85 | 0.19 | (5.70) | 3.01 | 9.00 | 27.62 |
ACELYRIN, INC Corporate Management
Patricia Turney | Chief Officer | Profile | |
Kenneth Lock | Chief Officer | Profile | |
Gilbert JD | Principal Officer | Profile | |
Shephard MD | Senior Development | Profile | |
Kelly Chow | Chief Officer | Profile | |
Ron Oyston | Chief Officer | Profile |